Review of non‐monotonic dose‐responses of substances for human risk assessment

Abstract

In this project, the evidence for the non-monotonic dose-response (NMDR) hypothesis was evaluated by critically reviewing the scientific peer-reviewed literature in the last decade (from 2002 onwards) for substances in the area of food safety. The project was performed according to the systematic review methodology. After a detailed analysis of previous reports published on the issue of NMDRs, a literature search was performed to identify in vivo, in vitro and epidemiological/human studies containing evidence for potential NMDRs. Inclusion and reliability criteria were defined and used to select relevant and reliable studies. Of studies with at least 5 dose groups, dose-response datasets were extracted and analysed by PROAST software package. The resulting dose-response results were evaluated for possible evidence of NMDR by applying six checkpoints. These checkpoints addressed both random and non-random errors. The plausibility of NMDRs was assessed based on the number of fulfilled checkpoints. In total, 202 in vivo datasets (from 49 studies), 311 in vitro datasets (from 91 studies) and 9 epidemiological/human datasets (from 2 studies) were identified. Among them, 179 in vivo and 13 in vitro dose-response datasets were analysed and evaluated using the checkpoints. For 23 in vivo datasets there were data limitations, which made the data unsuitable for dose-response analysis. For the in vitro studies, only continuous dose-response datasets presented in tables were analysed. None of the datasets from epidemiological/human studies could be analysed (one of the epidemiological studies was not analysed due to quantal data and the other due to data limitations).In most of the in vivo datasets, the apparent NMDR might have been caused by a single outlying dose group. In total, only 10 out of the 179 in vivo datasets fulfilled all six checkpoints. The latter datasets included studies on the substances quercetin, resveratrol, alpha-benzene hexachloride, and methylmercury. Review of NMDR of substances for HRA ContributorsAGES: Boehm T., Coja T., Hrdina-Zoedl B., Pacher-Zavisin M., Steinparzer R.ANSES: Charles S., Gouze M.E., Guillou P., Lehegarat L., Manière I., Ormsby J.N., Papadopoulos A., Printemps N., Roudot A.C.RIVM: Smeet E. Acknowledgements:RIVM: Ossendorp B., Vermeire T.IMM: Gornitzki C., Moberg K., Karolinska Institutet University Library Reproduction is authorised provided the source is acknowledged.Permission to reproduce the images must be sought directly from the copyright holder SummaryThe overall objective of this project was to evaluate the evidence for the non-monotonic doseresponse (NMDR) hypothesis by critically reviewing the scientific peer-reviewed literature in the last decade (from 2002 onwards) for substances (other than essential nutrients) in the area of food safety. MethodologyThe project was based on a systematic review including the steps of Preparing the review (review protocol, review question and criteria for study eligibility), Searching for research studies, Selecting the stu...

An exploratory analysis of the current chemical regulations and guidelines from the perspective of endocrine disrupting chemicals using public resources

“…In these published in vivo rodent studies on Dibutyl phthalate, the test concentration range for different endpoints is 0.01-1000 mg/kg/day across compiled studies in DEDuCT 2.0, the lowest dose at which an adverse effect is observed in any of these studies is 0.01 mg/kg/day, and the highest dose at which no adverse effects are observed in any of the studies is 125 mg/kg/day ( Supplementary Table S4). We remark that the compiled dosage information for Dibutyl phthalate in DEDuCT 2.0 is compatible with previous reports suggesting possible non-monotonic dose response for this chemical (Beausoleil et al, 2016).…”

Impacts of food contact chemicals on human health: a consensus statement

“…Chemicals with non-monotonic dose responses not only have increasing effects with increasing dose but may also have effects in the low-dose range [15,19]. A study commissioned by the European Food Safety Authority concluded that non-monotonic dose responses for several food-related chemicals (such as FCCs) could neither be confirmed nor rejected, and further investigation has been recommended [118]. Guidance for addressing this difficulty in chemical risk assessment has been published [119].…”

Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology

“…Finally, neurotoxicological studies on EDCs have brought to the attention of scientists and regulators three important issues that are usually underestimated and, in general, not properly addressed in other contexts: (i) the impact of low doses, (ii) long-term effects, and (iii) interactions occurring because of mixtures of compounds. It was observed, indeed, that EDC doses similar to environmental levels can have significant effects in experimental models, showing peculiar dose-response patterns that are not monotonic [119], even if this phenomenon has yet to be validated in other settings [120]. Moreover, EDCs can cause effects that only manifest much later in life than the period of exposure [121], most likely because of epigenetic mechanisms of information transmission: the exposure to the chemical could result in epigenetic modifications of the genome that can be inherited by future generations [122].…”